You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ropeginterferon alfa-2b

Showing 1 - 25 of 3,068
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Taipei (Ropeginterferon alfa-2b, SOC)

Not yet recruiting
  • COVID-19
  • Ropeginterferon alfa-2b
  • SOC
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 9, 2023

COVID-19 Trial in Taipei (P1101 (Ropeginterferon alfa-2b), SOC)

Active, not recruiting
  • COVID-19
  • P1101 (Ropeginterferon alfa-2b)
  • SOC
  • Taipei, Taiwan
    National Taiwan University Hospital
Mar 13, 2023

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Polycythemia Vera
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Essential Thrombocythemia
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Not yet recruiting
  • Polycythemia Vera (PV)
  • Mie, Japan
  • +5 more
Aug 15, 2023

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Chronic Hepatitis B Infection, Chronic Hepatitis D Infection Trial in Taipei City, Taipei city, Taoyuan city (P1101 + Nivolumab

Recruiting
  • Chronic Hepatitis B Infection
  • Chronic Hepatitis D Infection
  • P1101 + Nivolumab + Entecavir
  • Taipei City, Taiwan
  • +3 more
Sep 15, 2021

Hepatitis D Trial in Taipei (Ursodeoxycholic acid, Ropeginterferon alfa-2b, Tenofovir Alafenamide)

Not yet recruiting
  • Hepatitis D
  • Ursodeoxycholic acid
  • +2 more
  • Taipei, Taiwan
  • +1 more
Jul 19, 2022

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

Hepatocellular Carcinoma Trial in Taipei city (P1101 (Ropeginterferon alfa-2b), Nivolumab)

Recruiting
  • Hepatocellular Carcinoma
  • Taipei city, Taiwan
    National Taiwan university Hospital
Jan 25, 2022

Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

Recruiting
  • Hepatitis C, Chronic
  • P1101 + Ribavirin
  • Chiayi City, Taiwan
  • +7 more
Jun 30, 2022

Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

Recruiting
  • Polycythemia Vera (PV)
  • P1101 (Ropeginterferon alfa-2b)
  • Toon-shi, Ehime, Japan
  • +5 more
Jun 13, 2022

Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

Completed
  • Chronic Hepatitis C Virus Infection
  • P1101 + Ribavirin
  • PEG-Intron + Ribavirin
  • Beijing, China
  • +38 more
Jan 14, 2022

Polycythemia Vera Trial in China (Ropeginterferon alfa-2b)

Active, not recruiting
  • Polycythemia Vera
  • Ropeginterferon alfa-2b
  • Beijing, China
  • +13 more
Aug 1, 2022

Polycythemia Vera (PV) Trial in Japan (P1101, Low-dose aspirin, Phlebotomy)

Completed
  • Polycythemia Vera (PV)
  • Toon-shi, Ehime, Japan
  • +7 more
Dec 8, 2021

Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)

Recruiting
  • Essential Thrombocythemia
  • Phoenix, Arizona
  • +60 more
Dec 30, 2021

Healthy Volunteers Trial in Melbourne (ropeginterferon alfa-2b)

Completed
  • Healthy Volunteers
  • ropeginterferon alfa-2b
  • Melbourne, Victoria, Australia
    Nucleus Network Limited
Nov 22, 2019

Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

Recruiting
  • Essential Thrombocytopenia
  • Recombinant Interferon Alpha
  • Pegylated interferon alfa-2b
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 18, 2022

Chronic Hepatitis B Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (VIR-2218 and

Not yet recruiting
  • Chronic Hepatitis B
  • VIR-2218 and peginterferon alfa-2a
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 27, 2023

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
Has Results
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)

Active, not recruiting
Has Results
  • Malignant Melanoma
  • Peginterferon alfa-2b
  • +2 more
  • San Diego, California
  • +2 more
Apr 1, 2022

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022